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Posttranslational modification of a histone-like
protein regulates phenotypic resistance to
isoniazid in mycobacteria
Alexandra Sakatos,1 Gregory H. Babunovic,1 Michael R. Chase,1 Alexander Dills,1* John Leszyk,2
Tracy Rosebrock,1,3 Bryan Bryson,1 Sarah M. Fortune1,4†
There is increasing evidence that phenotypically drug-resistant bacteria may be important determinants of an-
tibiotic treatment failure. Using high-throughput imaging, we defined distinct subpopulations of mycobacterial
cells that exhibit heritable but semi-stable drug resistance. These subpopulations have distinct transcriptional
signatures and growth characteristics at both bulk and single-cell levels, which are also heritable and semi-stable.
We find that the mycobacterial histone-like protein HupB is required for the formation of these subpopulations.
Using proteomic approaches, we further demonstrate that HupB is posttranslationally modified by lysine acetylation
and lysine methylation. Mutation of a single posttranslational modification site specifically abolishes the formation
of one of the drug-resistant subpopulations of cells, providing the first evidence in prokaryotes that posttranslational
modification of a bacterial nucleoid-associated protein may epigenetically regulate cell state.
INTRODUCTION
Amajor clinical challenge in the tuberculosis field is that long courses of
treatment are required to clear infection. One compelling explanation
for the long treatment duration is that within a population of genetically
identical mycobacterial cells, there are subpopulations of cells that are
significantly less susceptible to antibiotics and that prolonged drug ex-
posure is required to clear these bacteria. The most commonly invoked
subpopulation of phenotypically drug-tolerant cells are so-called per-
sister cells. Persister cells were first identified as rare, nongrowing cells
that are able to withstand drug concentrations many times higher than
the minimum inhibitory concentration (MIC) (1). When persister cells
are regrown inmediawithout drug, the resulting progeny are killedwith
the same kinetics as the starting population (2). They are described as
“phenotypically” drug-tolerant, in contradistinction to genetically en-
coded alterations in drug susceptibility. “Drug tolerance” indicates that
the bacterium survives but not does grow in the presence of drug, where
growth in the presence of drug is considered “drug resistance” (3).
More recent work in bothmodel organisms andmycobacteria sug-
gests that persister cells should be viewed as the end of a continuum of
physiologic states and drug susceptibilities that exist within genetically
homogeneous bacterial populations. Recent studies of mycobacteria
have identified subpopulations of phenotypically drug-resistant cells
that arise at a relatively high frequency (4–10). Here, phenotypic drug
resistance tracked between sister cells, suggesting that drug resistance
was epigenetically regulated in these actively growing subpopulations
(8). However, the molecular mechanisms underlying the emergence
of phenotypically drug-resistant populations of mycobacterial cells re-
main unclear.
To address this question, we used an adaptation of a previously
established high-throughput dynamic imaging technique to identify
and characterize bacterial subpopulations that grow in the presence of
drug (11). This approach allowed us to define subpopulations of myco-
bacterial cells that grow in the presence of the first-line antitubercular
antibiotic isoniazid (INH). Using comprehensive transcriptional profil-
ing and live-cell imaging, we define two subpopulations, large and small
colony variants (LCVs andSCVs),withdistinct transcriptional signatures
and growth properties. The drug resistance and growth characteristics of
these subpopulations are heritable and semi-stable, suggesting that they are
epigenetically regulated. We find that the nucleoid-associated protein
HupB is required for the formation of these phenotypically drug-resistant
subpopulations. HupB is posttranslationally methylated and acetylated
at lysine residues, andpreviousworkdemonstrates thatHupB lysine acet-
ylation alters chromatin structure (12). We demonstrate that mutation
of a single HupB posttranslational modification site results in the spe-
cific loss of the SCV subpopulation. These findings support a model
whereby posttranslational modification of HupB heritably alters gene
expression and phenotypic state in a subpopulation of mycobacterial
cells, akin to epigenetic regulation through the posttranslational modi-
fication of eukaryotic histones.
RESULTS
Growth in the presence of drug defines
mycobacterial subpopulations
To identify subpopulations ofmycobacteria that grow in the presence of
drug, we used an adaptation of ScanLag, a technique that combines
plating with high-throughput dynamic imaging to identify rare bacte-
rial subpopulations with distinct growth properties (11). We used
Mycobacterium smegmatis (mc2155), a model mycobacterium with a
relatively rapid doubling time that is used as a tractable model for
Mycobacterium tuberculosis. M. smegmatis was grown in standard
media (7H9 with OADC, Tween 80, and glycerol) without drug and
then plated onmedium containing the bactericidal antibiotic INH at a
range of concentrations around the MIC established in broth culture
(10) and on plates (Fig. 1A). In broth culture, as the drug concentra-
tion approachesMIC90, there is a slowing but not complete inhibition
of the bacterial population’s growth. We reasoned that at MIC90 con-
centrations of drug, the entire population might be growing slowly but
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homogeneously, and in this case, all the cells platedwould form colonies
slowly at the same time. Alternatively, if slow bulk growth reflects the
average of growth inhibition for the majority of the bacterial popu-
lation mixed with a rare, faster-growing subpopulation, only the sub-
set of growing cells would form colonies. We observe the latter; as drug
concentration increases, a subset of the plated cells forms colonies
(Fig. 1A). When M. smegmatis is plated on medium at the concen-
tration of INH, at which ~10% of cells form colonies (4 mg/ml), these
colonies emerge at two distinct time points (Fig. 1, B, D, and E), ul-
timately generating a bimodal distribution of colony sizes (Fig. 1E).
This suggests the presence of two distinct cell lineages that grow in
the presence of drug. These findings are qualitatively similar to the col-
ony variants observed inM. tuberculosis, even in the absence of drug
exposure (Fig. 1C and fig. S1), although there was a broader range of
colony sizes observed inM. tuberculosis than inM. smegmatis. In the
setting of drug exposure, as INH concentrations increase toward
MIC90, slowed bulk population growth also appears to reflect the se-
lection of a subpopulation of cells able to form colonies on drug (Fig. 1C
and fig. S1).
Phenotypic drug resistance is heritable and semi-stable
The cells that grow on concentrations of INH near the MIC are able to
form colonies, indicating that their drug resistance is at least partially
heritable. To determine the stability of the drug-resistant phenotype,
SCVs and LCVs ofM. smegmatiswere picked into liquidmediumwith-
out drug and then replated on INH after various periods of outgrowth.
Upon immediate reexposure to antibiotics, the progeny of both the
SCVs and LCVs exhibited significantly increased INH resistance as
compared to the unselected starting population ofM. smegmatis cells
(Fig. 2A). With increasing time in culture, this increased resistance
was gradually lost such that after 96 hours of culture, the cultured
LCV and SCV cells recapitulated the drug susceptibility of the
starting population (Fig. 2A).
Variants have distinct growth properties
In addition to demonstrating semi-stable drug resistance, the colony
morphotypes are also heritable and semi-stable. Thus, when cells from
small colonies are replated, they produce more small colonies than cells
from large colonies (Fig. 2B). However, after 96 hours of culture, the
Fig. 1. Identification of mycobacterial subpopulations that grow in the presence of drug. (A, B, D, and E) M. smegmatis. (C) M. tuberculosis. (A) Colonies formed on
INH plates with indicated concentrations as a percentage of colonies formed on plates without drug. (B) Time of initial detection of colonies, as determined by CellProfiler, in
the presence and absence of INH (4 mg/ml). (C) Distribution of M. tuberculosis colony sizes after 22 days of growth on INH. (D) Example series of one plate tracked over time
with CellProfiler (INH, 4 mg/ml). Plates were run through custom program, and colored circles indicate the actual size of the detected colonies. (E) Histogram of major axis
length of colonies for all colonies plated over time (INH, 4 mg/ml).
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Fig. 2. Phenotypic drug resistance is heritable and semi-stable. (A) Small and large colonies were picked, resuspended in liquid media, and plated immediately (t = 0)
and then passaged through liquid media without drug and plated at indicated time points. Ratio of colonies on INH plates/plates without INH was measured. SP,
starting population. Significance was determined by unpaired t test. (B) LCVs and SCVs were picked from INH plates, resuspended in 7H9 media, and replated onto
plates without drug. The histograms of the resulting colony sizes from each colony type after immediate replating are shown. (C) Large and small colonies were picked
from INH plates, and cells were loaded into a microfluidic device and imaged for ~48 hours in media with INH (4 mg/ml). (D) Quantification of cell size at birth.
Significance was determined by unpaired t test. (E) Quantification of time from birth to division for individual cells. Significance was determined by unpaired Student’s
t test. For all panels, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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distribution of colony sizes from LCV and SCV cells is indistinguishable.
These data suggest that the different colony morphotypes arise from
cells with different growth parameters. To test this hypothesis, the
growth characteristics of LCVs and SCVs were assessed at a single-cell
level in the presence of INH using live-cell imaging (Fig. 2C). Both
cells from LCVs and SCVs grow and divide in the presence of INH
at 4 mg/ml (Fig. 2C), unlike cells from the starting population and
consistent with the plating data. Cells from LCVs are significantly lon-
ger (Fig. 2D) and have shorter division times (Fig. 2E) compared to cells
from small colonies.
Variants have distinct transcriptional signatures
We hypothesized that differences in transcriptional state underlie the
distinct growth properties of the cells forming LCVs and SCVs. To test
this hypothesis, we created pools of LCVs and SCVs and performed
RNA sequencing (RNA-seq). DESeq analysis identified extensive tran-
scriptional differences between the LCVs and SCVs (Fig. 3, A and B),
suggestive of broad transcriptional repression in the small colony cells
(13–15). Five hundred thirty-three genes were found to be significantly
down-regulated (fold change > 2, P < 0.01) in the SCVs, including ~20
genes that were down-regulated more than 10-fold (Fig. 3C and table
S2). The differentially expressed genes included genes implicated in
metabolic functions [such as MSMEG_5568 (clavaldehyde de-
hydrogenase), MSMEG_0894 (dihydrodipicolinate reductase), and
MSMEG_3362 (enoyl–coenzymeAhydratase)] and transcriptional reg-
ulation (such as arsR,marR, and tetR), consistentwith broad differences
in cellular physiology (accession numbers SRR5507179, SRR5507182,
SRR5507184, and SRR5507185). Neither katG nor inhA was differen-
tially expressed in SCVs, suggesting that the mechanism of phenotypic
drug resistance is not differential transcription of the activator or target
of INH.
HupB is required for the formation of drug-resistant variants
The frequency at which these INH-resistant cells arise and revert was
too high to be due to known mutational mechanisms inM. smegmatis
(16). To assess the possibility that they arise through an alternative
mutation mechanism that generates high-frequency genetic variation,
whole-genome sequencing (WGS) of LCVs and SCVs was performed.
There were no individual mutations or mutated genes in recognizable
pathways associated exclusively with either variant type (accession
numbers SRR5507164, SRR507165, SRR5507174, SRR507175,
SRR5507176, and SRR5507177). Thus, we hypothesized that a novel
epigenetic mechanism governs the formation of these drug-resistant
subpopulations.
HupB is a nucleoid-associated protein that has previously been
implicated in growth regulation and survival after INH exposure
(17–19). Deletion of hupB does not alter the growth of M. smegmatis
in 7H9 medium (fig. S2), although it is essential for bacterial survival
in M. tuberculosis (20). Previous work using bulk assays including
alamar blue and an agar diffusion test has shown that a hupB deletion
mutant is more susceptible to INH treatment (17, 18). Here, we quan-
tified the number of wild-type (WT) and hupB mutant colonies on
increasing concentrations of INH. Consistent with the previously
published work, we found that the hupB deletionmutant is significantly
less able to survive when plated on concentrations of INHnear theMIC
(Fig. 4A). The slope of the growth inhibition curve at these INH con-
centrations was steeper in the hupB deletionmutant as compared to the
WT strain. This finding suggests that deletion of hupB results in the loss
of a subpopulation of phenotypically drug-resistant cells, rather than
affecting the growth of the entire population. These defects can be
complemented with an integrated copy of WT hupB expressed from
its native promoter (Fig. 4A). The hupB deletion mutant has defects
in the formation of both LCVs and SCVs (Fig. 4B).
The impact of hupB on gene expression has not previously been
determined in mycobacteria, although work on homologues in other
organisms suggests that it is responsible for the maintenance and plas-
ticity of the bacterial chromosome (21–24). Consistent with this model,
RNA-seq analysis of the hupB deletionmutant as compared toWT cells
demonstrated that loss of hupB results in derepression of 77 genes (Fig.
4C and table S3; BioSample accession numbers SAMN06770114 and
SAMN06770117). Gene set enrichment analysis (GSEA) demonstrated
that the genes that are up-regulated in the hupB deletion mutant sig-
nificantly overlap with those that are down-regulated in the SCVs
(Fig. 4D), including genes involved in metabolism (MSMEG_2659 and
MSMEG_3198) and transcriptional regulation (MSMEG_3960 and
MSMEG_6451), suggesting a model whereby HupB-mediated repres-
sion of gene expression through its action on chromatin state might bi-
furcate the population into SCVs and LCVs (25).
Mutation of a HupB modification site alters gene expression
and results in specific loss of small variant subpopulation
Published studies have demonstrated that mycobacterial HupB has an
unusual structure, composed of an N-terminal domain that is homol-
ogous to other prokaryotic HU proteins and a C-terminal domain that
Fig. 3. Variants have distinct transcriptional signatures. Pools of LCVs and
SCVs were assayed in duplicate. (A) Hierarchical clustering analysis of genes dif-
ferentially expressed more than threefold. (B) Volcano plot analysis of RNA-seq
data comparing gene expression profiles of SCVs and LCVs. Dots indicated in
red and blue are genes that are down-regulated and up-regulated, respectively,
in the SCVs more than twofold with a P value of <0.01. (C) Gene categories of
genes differentially expressed >10-fold in LCVs versus SCVs.
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contains a tetrapeptide repeat characteristics of eukaryotic histone
H1 proteins (26, 27). Studies have identified lysine acetylation and
serine/threonine phosphorylation sites in the N-terminal domain of
M. tuberculosis HupB and have further shown that in vitro acetylation
of HupB alters its chromatin binding capacity (12, 28).We performed a
whole-cell proteomic screen usingWTM. smegmatis grown in 7H9 and
found evidence that thesemodification sites are conserved inM. smegmatis
(fig. S3) (28, 29). To confirm these modification sites, we purified a
His-tagged version of HupB fromM. smegmatis and performed liquid
chromatography–tandemmass spectrometry (MS) on the purified pro-
tein, confirming sixmethylated and acetylated sites (Fig. 5, A andC, and
fig. S4). Strikingly, three of six of the modified sites were identified as
putative DNA binding sites in the published crystal structure of the
N-terminal domain of HupB (Fig. 5B) (30), suggesting that modifica-
tion of these sites might modulate the DNA binding capacity of HupB
and thereby alter gene expression.
We used a genetic approach to test the importance of the HupB
modification sites for the HupB-dependent formation of INH-resistant
colonies because many of these sites appear to be the target of several
modifications, which made quantitative comparison of modification
levels challenging. We complemented the hupB deletion mutant with
hupB alleles in which we systematically mutated the lysinemodification
sites to arginine or alanine. We first assessed the impact of these muta-
tions on protein abundance as determined by Western blot analysis.
Many of themutations appear to grossly destabilizeHupB, but we iden-
tified two highly conservative mutations, K86R and R55K, that do not
alter protein abundance (fig. S5).We focused onHupBK86R for further
characterization because mycobacteria carrying this mutation display
WT growth characteristics when grown in 7H9 medium (fig. S2).
RNA-seq analysis of the DHupB_pjeb:WT and DHupB_pjeb:K86R
strains demonstrated that the K86Rmutation does not alter gene ex-
pression at a bulk level (accession numbers SAMN06770114 and
SAMN06770115).
We sought to assess the effect of disrupting the K86 modification
site on the ability of M. smegmatis to survive when exposed to con-
centrations of INH near the MIC. We compared the ability of the
M. smegmatis hupB deletion mutant complemented withWT hupB
or the K86R variant to form colonies on INH. The K86R mutant forms
significantly fewer colonies when plated on INH (Fig. 6A). Strikingly, al-
though the K86R mutant strain forms LCVs at the same rate as the WT,
this mutation results in the specific loss of SCV formation (Fig. 6, C to E).
DISCUSSION
In M. tuberculosis infection, there is a biphasic response to antibiotic
treatment, where roughly 90% of bacteria are killed within the first
few days after treatment, whereas the last 10% of the population exhibit
a significantly slower rate of clearance (31). The recalcitrance of this
subpopulation to antibiotics is thought to be partially responsible for
the extended treatment periods required to fully clearM. tuberculosis
infection (31). The makeup of this slowly eliminated drug-tolerant
bacterial subpopulation is largely unknown, although transcriptional
adaptation has been hypothesized to play a role (31).
These observations have generated interest in understanding the
mechanisms and drug susceptibilities of phenotypically distinct subpo-
pulations ofmycobacterial cells. Until recently, bacterial subpopulations
have largely been understood in terms of the persister cell paradigm.
However, recent studies have demonstrated that in mycobacterial
Fig. 4. Loss of HupB results in significant reduction of colony formation in the presence of INH and alters gene expression. (A) Percent survivors were calculated
from the number of colonies counted on the plates with drug as compared to the number of colonies on the plates without drug. (B) Representative images of
DHupB_pjeb:WT and DHupB_pjeb:empty vector plated on INH (4 mg/ml). (C) RNA-seq analysis comparing gene expression patterns in DHupB_pjeb:WT and
DHupB_pjeb:empty. Dots indicated in green are up-regulated in the DHupB_pjeb:empty strain. Strains were collected at late stationary phase. (D) GSEA of genes
differentially expressed in DHupB_pjeb:empty strain versus DHupB_pjeb:WT as compared to the genes identified as down-regulated more than fourfold with a P value
of <0.01 using DESeq analysis in comparison to SCV versus LCV. ES, enrichment score.
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populations, there is an array of phenotypically distinct cells, recogniz-
able because of differences in drug susceptibilities. They arise and revert
at different frequencies and are characterized by different growth proper-
ties and themagnitude of their drug resistances. The relative importance
of any given subpopulation for treatment failure has been impossible to
assess, however, because there is no mechanistic understanding of their
formation or genetic path to modulate their emergence.
We find that treating M. smegmatis with concentrations of INH
near theMIC kills most, but not all, of the bacteria in the population.
The surviving cells are composed of two distinct, epigenetically regu-
lated lineages of bacteria, distinguishable as SCVs and LCVs, which
continue to grow in the presence of drug. The cells in these variant
populations have distinct transcriptional profiles, growth properties,
and altered drug susceptibility that are semi-heritable and cannot be
explained by underlying genetic mutations.
Variable colony phenotypes have previously been observed in re-
sponse to stressors in other organisms. SCVs in Staphylococcus aureus
were first discovered in the early 1900s. Interest in them increased in the
last couple of decades due to growing evidence that SCVs are associated
with chronic, persistent infections that are notoriously difficult to treat
(32, 33). SCVs have since been identified in other bacteria, including
Pseudomonas aeruginosa, and occur in response to a variety of in vitro
and in vivo stress conditions (34–36).
Still, the term SCV is descriptive and does not imply a commonmo-
lecularmechanism. The SCVs that have been identified under this array
of conditions have fallen into two broad classes: (i) stable SCVs that do
not revert to the normal colony phenotype upon subculture and are
caused by an underlying genetic mutation, and (ii) unstable SCVs that
rapidly revert to the normal colony phenotype upon subculturing.
Stresses such as antibiotics and starvation have been shown to increase
lag times of individual cells (37). Therefore, it has remained unclear
whether unstable SCVs are formed by a founding cell population with
increased lag times, or if the SCVs are composed of a lineage of cells that
heritably grow differently in the presence of the applied stress. These
two alternative models imply different underlying mechanisms and
biological consequences, and thus, discriminating between them is
important to improve our understanding of bacterial survival strategies.
Here, we show that in mycobacteria, two distinct colony variant types
grow in the presence of INH. These SCV and LCV subpopulations
are composed of cells with distinct, heritable, growth properties and
gene expression profiles, consistent with the latter model. These sub-
populations together likely contribute to the overall INH tolerance of
M. smegmatis that is observed with population-level assays.
We also demonstrate that the mycobacterial histone-like protein
HupB is required for the formation of these drug-resistant subpopu-
lations. Our experiments do not formally determine whether HupB-
regulated subpopulations are preexisting in the population or whether
they arise de novo in the face of drug treatment. The high rate at which
we detect these resistant populations in the presence of drug (up to 10%
of the population) suggests that antibiotic stressmay increase the capac-
ity of the bacteria to form these variants; however, future experiments
must be done to discriminate between these possibilities.
We and others have also found that HupB is highly posttranslation-
ally modified at lysine, serine, and threonine residues (12, 28). We find
both modified and unmodified peptides in our analysis, suggesting that
thesemodifications are present on only a subset of theHupBproteins in
a bacterial cell culture.We demonstrate thatmutation of a single lysine,
which appears to have thepotential to be both acetylated andmethylated,
Fig. 5. Posttranslational modification sites on HupB. (A) Modified amino acids and posttranslational modification sites on HupB identified by whole-cell proteomics.
(B) Predicted structure of M. tuberculosis HupB reprinted with permission from Bhowmick et al. (30). Modified amino acid residues identified in this study are circled. The
K86 residue, the spectrum of which is depicted in (C), is circled in black. (C) MS/MS of tryptic peptide identified after a Mascot database search, where methylation on
Lys86 can be inferred from the peptide mass/charge ratio (m/z) and the ion fragmentation pattern.
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results in the specific loss of the SCV subpopulation. Our studies do
not resolve which modification of K86 is causally related to SCV for-
mation. Our efforts to use quantitative proteomics to compare levels of
modified K86 between SCV and LCV failed to demonstrate significant
differences, suggestingmore complex models whereby combinations of
HupB modifications or modification at earlier stages of cellular differ-
entiation drives SCV formation.
Previously established mechanisms of epigenetic inheritance in
bacteria, such as DNAmethylation and positive feedback loops, typical-
ly involve regulation of only one or a few genes (38–40). Our findings
suggest the existence of a fundamentally distinct form of epigenetic reg-
ulation in prokaryotes, whereby modification of a histone-like protein
has widespread effects on gene expression that are inherited across gen-
erations and bifurcates the populations into two distinct cell types. In
eukaryotes, it is well established that histones can package chromosomal
DNA into domains of varying compaction and transcriptional activity.
A similar role for bacterial histone-like proteins in the structural or-
ganization of the bacterial nucleoid has more recently begun to be ap-
preciated (24, 41, 42). Accordingly, a recent study showed that
acetylation alters the ability of mycobacterial HupB to bind and
compact DNA, suggesting a plausible mechanism by which these her-
itable changes in cell state and gene expression could be implemented
(12). This form of heritable epigenetic regulationmirrors the role of his-
tonemodifications in eukaryotes and is the first indication that an anal-
ogous mechanism may exist in bacteria. Histone modifications were
recently shown to drive the induction of a reversibly drug-tolerant state
Fig. 6. K86R mutation results in the preferential loss of small colonies. (A) Total colony formation in the presence of INH (4 mg/ml) as a percentage of colonies
formed on plates without drug. Colonies were counted after 7 days. (B) Representative plates of indicated strains plated on INH (4 mg/ml) at day 7. (C) Representative
plates tracked over time using CellProfiler. (D) Histograms of colony sizes on INH plates (4 mg/ml) at day 7. Frequency distribution between DHupB_pjeb:WT and
DHupB_pjeb:K86R is significantly different as determined by the Kolmogorov-Smirnov (KS) test. (E) Number of SCVs and LCVs at day 7 on INH plates (4 mg/ml). In
(A) and (E), significance is determined by the Mann-Whitney test and is indicative of over 10 independent biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001, ****P <
0.0001. NS, not significant.
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in subpopulations of cancer cells, suggesting unexpected parallels of
drug survival strategies across these distant cell types (43).
Although here we used sublethal antibiotics to isolate these pheno-
typic variants, colony size variation has been observed in mycobacteria
in a variety of conditions. At a single-cell level, semi-heritable pheno-
typic variation has been observed inM. tuberculosis in response to anti-
biotic and immune stress (44). These findings, together with our work,
suggest that perhaps SCVs and LCVs may be privileged, epigenetically
regulated subpopulations that are selected for under a variety of con-
ditions and contribute to the recalcitrance ofM. tuberculosis to immune
control and antibiotic treatment.
MATERIALS AND METHODS
Bacterial plating assay
M. smegmatis cultures were started from individual colonies in tripli-
cate and grown to stationary phase (approximately 2 days) in supple-
mented 7H9 broth (7H9 with OADC, 0.05% Tween 80, and 0.2%
glycerol). Cultures were then normalized, back-diluted, and grown
to an optical density (OD) of ~1.0. Cultures were then diluted from
10 × 10−3 to 10 × 10−5, and 100-ml aliquots were plated on 7H10 plates
[7H10 supplemented with OADC (Middlebrook) and 0.05% Tween
80]. INH was diluted in water at 5 mg/ml and added to plates at indi-
cated concentrations. Plates were incubated at 37°C for the indicated
periods of time. Plates were imaged at defined time points following
plating, and images were analyzed using a custom CellProfiler pipeline
to count and measure the size of colonies.
M. tuberculosis drug responses
M. tuberculosis H37Rv was grown to mid-log phase in supplemented
7H9. The culture was gravity-filtered through a 5-mm syringe filter
(Millipore) and further diluted in the same media before plating on
7H10 containing varying concentrations of INH. Plates were incubated
for 22 days at 37°C before measurement of colony size.
Live-cell imaging
Small and large colonieswere picked from7H10plateswith INH(4mg/ml)
and resuspended in 1ml of supplemented 7H9 containing INH (4mg/ml)
and sonicated. Cells were loaded onto a custommicrofluidic device and
imaged on a DeltaVision microscope, as previously described (10).
Images were acquired every 10 min for 48 hours.
Reversion assays
Small and large colonies were picked from 7H10 plates with INH
(4 mg/ml), resuspended in 1ml of supplemented 7H9, sonicated, diluted
as indicated, and plated either directly or after the indicated period of
growth in supplemented 7H9 medium without drug. Cells were plated
on 7H10 plates with and without INH.
RNA-seq analysis
Cells were harvested and resuspended in 1 ml of TRIzol and disrupted
via bead beating. RNA was extracted using Direct-zol columns (Zymo
Research), and ribosomal RNAwas removed using a magnetic Ribo-
Zero Bacteria kit (Illumina). Libraries were prepared with the KAPA
mRNA-Seq Kit and sequenced on the MiSeq (Illumina). Reads were
aligned with Burrows-Wheeler Aligner (BWA) using the BWA-MEM
algorithm (45). Alignments were processed with SAMtools (46). Read
counts were obtained with HTseq-count FIX using theM. smegmatis
mc2155 reference sequence (NC_008596) (15). Differential gene ex-
pression analysis was done with the R package DESeq2 (47). GSEA
was performed as previously described (25). Differentially expressed
genes in between the indicated strains were preranked on the basis of
log-fold change and then compared via GSEA to genes down-regulated
fourfold or greater in the small colonies.
Whole-genome sequencing
Small and large colonies were isolated from three independent cultures
and grown in 5 ml of supplemented 7H9 overnight. Cells were pelleted
and DNA was extracted as described previously (48). Libraries were
prepared with the Nextera XT Kit and sequenced on the MiSeq at a
depth of ~2million reads per sample. To identify polymorphisms, reads
were aligned with BWA using the BWA-MEM algorithm (45). Align-
ments were processed with Pilon (49).
Unbiased proteomic analysis
Data from our previously published whole-cell proteomic analysis of
M. tuberculosisH3Rv were reanalyzed to identify posttranslationally
modified peptides (50). Spectra were searched against a database that
contained the predicted open reading frames (ORFs) in the genome of
H37Rv supplemented with common contaminates using SEQUEST
(Thermo Fisher Scientific). Carbamidomethylation on cysteine was spec-
ified as fixedmodification, and oxidation onmethionine, acetylation on
lysine, and acetylation on protein N terminus were specified as variable
modifications. Peptides were filtered at a 1% false discovery rate with
PeptideProphet and grouped into proteins with ProteinProphet with
a cutoff of 0.95.
Construction of hupB deletion and mutant strains
A hupB deletion strain was constructed using previously published
protocols to make unmarked deletion mutants by allelic exchange (51).
To generate complementation constructs in which hupB is expressed
under its native promoter, the hupB ORF and 200 base pairs upstream
of the ORF were cloned into the integrating mycobacterial expression
vector pJEB402 using Xba I andHind III site-directedmutagenesis per-
formed using the QuikChange protocol (Agilent). To generate His-
tagged hupB, a 6× His tag was cloned at the C terminus of hupB.
HupB purification
His-tagged hupB was expressed in M. smegmatis under its native
promoter, as described above. To purify the protein, cells expressing
His-tagged hupB or negative control cells containing an empty vector
were cultured in supplemented 7H9 with kanamycin (25 mg/ml) to an
OD of ~1.0. Cells from 1 liter of culture were pelleted, and pellets were
resuspended in lysis buffer [200 mMNaCl, 50 mM tris-HCl (pH 7.9),
0.1 mM EDTA, 0.1 mM dithiothreitol, and 5% glycerol]. Cells were
lysed using a French press, and debris was removed by centrifuging
for 10 min at 10,000 rpm. Supernatant was added to cobalt beads
(TALON) and incubated overnight at 4°. Beads were spun down at
low speed and liquid was removed, and then beads were washed three
times for 10 min in wash buffer [50 mM tris-HCl (pH 7.9), 0.1 mM
EDTA, 500 mMNaCl, and 10 mM imidazole]. HupB was eluted with
1ml of elutionbuffer [50mMtris-HCl (pH7.9), 0.1mMEDTA, 400mM
NaCl, and 500 mM imidazole]. Eluate was mixed with 2× tricine SDS–
polyacrylamide gel electrophoresis buffer (Life Technologies) and run
on a 10 to 20% tricine gel (Life Technologies). Expressed HupB was
identified by Coomassie staining at the expected molecular weight and
not present in the negative control. TheHupB bandwas cut out, and in-
gel digestion with trypsin was performed (52).
SC I ENCE ADVANCES | R E S EARCH ART I C L E
Sakatos et al., Sci. Adv. 2018;4 : eaao1478 2 May 2018 8 of 10
 o
n
 July 12, 2018
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
A 4.0-ml aliquot was directly injected onto a custom-packed 2 cm ×
100mmC18Magic 5-mmparticle trap column. Peptideswere then eluted
and sprayed from a custom-packed emitter (75 mm× 25 cm C18 Magic
3-mm particle) with a linear gradient from 95% solvent A (0.1% formic
acid in water) to 35% solvent B (0.1% formic acid in acetonitrile) in
60min at a flow rate of 300 nl/min on aWaters nanoACQUITYUPLC
system. Data-dependent acquisitions were performed on a Q Exactive
mass spectrometer (Thermo Fisher Scientific) according to an exper-
iment, where full MS scans from 300 to 1750 m/z were acquired at a
resolution of 70,000 followed by 10 MS/MS scans acquired under
high-energy collisional dissociation fragmentation at a resolution of
17,500with an isolation width of 1.6Da. Raw data files were processed
with Proteome Discoverer (version 1.4) before searching with Mascot
Server (version 2.5) against theM. smegmatis database. Search param-
eters used were tryptic with two missed cleavages, parent mass toler-
ances of 10 parts per million, and fragment mass tolerances of 0.05 Da.
A fixed modification of carbamidomethyl cysteine, variable modifica-
tions of acetyl (protein N-term and lysine) and pyroglutamic for N-term
glutamine, oxidation of methionine, and mono-, di-, and trimethylation
of lysine and arginine were considered. Search results were loaded into
the Scaffold Viewer (Proteome Software Inc.) for assessment of protein
identification probabilities and label-free quantitation.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/5/eaao1478/DC1
table S1. Bacterial strains used in this study.
table S2. Genes down-regulated >10-fold in small versus large colonies.
table S3. Genes up-regulated more than fivefold in HupBD versus WT.
fig. S1. M. tuberculosis colony sizes and numbers plated on increasing concentrations of INH.
fig. S2. M. smegmatis strains expressing WT and mutant HupB alleles grown at WT rates.
fig. S3. Modifications identified in previous study and current work.
fig. S4. His-tagged HupB was purified fromM. smegmatis, and modifications were identified by MS.
fig. S5. Effects of disrupting HupB modification sites on HupB protein abundance.
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